Fueled by data from the FINTRX Private Wealth Data Platform, which provides intel into thousands of direct deal transactions made by over 3,700+ family offices worldwide, we highlight five family offices making investments in the healthcare industry.
Nihar Parikh is an esteemed entrepreneur and private investor in the healthcare sector, who began his professional journey with Zandu Pharmaceuticals. In 2022, he established 4Point0 as a family office dedicated to managing and investing his family's wealth. Headquartered in Mumbai, India, the firm's overarching mission is to propel emerging companies to new heights, fostering market disruption while securing their own generational prosperity.
At present, 4Point0 primarily directs its investments towards venture-staged private companies through direct investments. While the firm maintains a global outlook in deal sourcing, it primarily favors ventures situated in Asia, particularly in India and the surrounding region. Notably, 4Point0 takes a targeted approach in evaluating new portfolio companies, exclusively focusing on health-tech venture-stage startups. Their investment philosophy hinges on identifying companies where the group's strategic input can create substantial value, forging successful partnerships with founders and investors alike.
In July 2022, the office made a significant $12 million investment in Fitterfly, a digital therapy platform catering to weight loss and diabetes management. Fitterfly's services extend support to individuals with type one and two diabetes, as well as those seeking effective solutions for stubborn weight loss and other metabolic conditions. Leveraging their user-friendly app, Fitterfly provides easy access to proven care programs, earning accolades for their award-winning digital therapeutics and clinical efficacy. According to reputable sources like Entrepreneur, “The funding will be used to increase the reach of Diabefly, their award-winning digital therapeutics and clinically-proven program.” Just three months later, In October 2022, the Parikh family office participated in a $4.5 million funding round for Saveo, a pioneering B2B managed pharmaceutical marketplace. Saveo's mission revolves around ensuring universal access to essential drugs in India by streamlining shipping processes, reducing costs, and leveraging advanced technologies for pharmacies.
Established in 2012, Interplay Family Office is a reputable multi-family office and registered investment advisor based in New York, NY. The firm specializes in effectively managing the wealth of a select group of high-net-worth individuals and families, offering a comprehensive range of family office services, including asset allocation, estate planning, tax management, reporting, and philanthropic support.
Over the years, Interplay Family Office has maintained a minimum relationship size requirement of $25M to open an advisory account. The distinguished management team of Interplay Family Office leverages its extensive network to access alternative assets and collaborate with professionals, providing clients with tailored advice and driving significant added value to their investments.
Presently, the firm pursues diverse investment opportunities across various asset classes, such as public and private equity, venture capital, real estate, mutual funds, fixed-income, private placements, ETFs, and direct investments, among others. The company adopts a global perspective when sourcing investments, considering a wide range of geographic exposures. While historically focusing on the technology sector, Interplay Family Office currently holds a broader mandate, spanning multiple industries and stages of development. Their in-house research team employs a variety of analytical methods, including charting, technical, fundamental, cyclical, and other analyses to make informed investment decisions.
In December of 2022, Interplay Family Office facilitated a notable $3.5 million venture round into Fertilidad Integral, a prominent Mexican healthcare company based in Mexico City. The company offers cutting-edge fertility treatments, complemented by a holistic approach to patient care, catering to various related needs. Similarly, in December of 2021, the firm participated in a significant $50 million series B funding round for Ophelia, a New York-based company specializing in online opioid addiction treatment. According to Globe News Wire, the company, which treated its first patients in 2020 and is now in 27 states, provides treatment directly to customers instead of relying on care from conventional medical providers. Working to end the epidemic of overdoses in the U.S, the company provides medication-assisted treatment (MAT), which is the gold standard for opioid addiction care, and is proven to reduce overdoses by 75 percent.
In 2014, Dolby Family Ventures was established in San Francisco with the primary purpose of managing and investing the wealth of the Dolby family. Ray Dolby, a renowned engineer and inventor of the Dolby NR noise reduction system, founded Dolby Laboratories, an organization dedicated to designing and producing cutting-edge audio technology.
Taking a long-term, partner-oriented approach to investments, Dolby Family Ventures not only provides capital but also offers invaluable business expertise and industry-specific knowledge and networking opportunities to their portfolio companies. The office shows particular interest in early-stage funding rounds, with core investment interests spanning digital media, cloud technology, security, and healthcare technology. Dolby Family Ventures can write checks ranging in size from $300K to around $3M and chooses to only participate in co-investments.
Over the past two years, Dolby Family Ventures has made significant early-round investments in the healthcare sector. In May 2023, they participated in a venture round, contributing to a total of $33 million raised by Paradromics. Paradromics is a pioneering company working on developing a direct data interface with the brain. The ultimate goal is to aid patients with severe paralysis in regaining the ability to communicate by mapping and understanding their neural signals. According to Finsmes, the funds will be used to help launch their first human clinical trial for their technologies.
Another notable investment made by Dolby Family Ventures was in May of the same year, when they played a pivotal role in helping Genemod secure $4.5 million in a seed round. Genemod, a promising startup based in Seattle, WA, focuses on developing a cloud-based platform that assists life sciences companies and researchers in managing their work and data efficiently. The newly acquired funds will be allocated towards expanding their workforce and scaling their go-to-market operations, as reported by GeekWire.
The Duquesne Family Office was established in 2010 in New York, NY to manage and invest the wealth of Stanley Druckenmiller and his family. Druckenmiller is an esteemed American investor, hedge fund manager, and philanthropist. Notably, he served as the former chairman and president of Duquesne Capital, a hedge fund he founded in 1981, which ultimately concluded its operations in 2010, with assets under management exceeding $12 billion at the time of closure.
The investment focus of the Duquesne Family Office predominantly centers around private equity, hedge funds, venture capital, and fund of funds. The firm employs a global approach to its investment strategies and demonstrates keen interest in a wide diversity of sectors, encompassing technology, healthcare, food & beverage, travel, media, and other significant domains. Of particular significance is the recent sizable investment portfolio allocated to the healthcare sector.
In June 2021, the Duquesne Family Office participated in a momentous $85 million series G funding round for PROCEPT BioRobotics. PROCEPT, headquartered in Redwood, California, holds the distinction of being the world's first company dedicated to the development of autonomous surgical robots for the treatment of benign prostatic hyperplasia (BPH). Cision's report indicated that the proceeds from the funding round are to be used for supporting the global expansion of PROCEPT's groundbreaking product into new and promising markets.
More recently, in February 2023, the Duquesne Family Office made a noteworthy investment in Ratio Therapeutics, a prominent pharmaceutical company based in Boston, MA. Specializing in the development of targeted radiotherapeutics for cancer treatment, Ratio Therapeutics secured a substantial $20 million in a series A funding round. The utilization of these new funds is aimed at optimizing and expanding their Trillium and Macropa technology services, accelerating the development of their advanced targeted radiotherapy technology, and expanding their team through strategic onboarding and the establishment of new alliances.
Cox Enterprises, established in 1898 and headquartered in Atlanta, Georgia, is a prominent single family office tasked with overseeing the financial assets of the Cox family. The family's wealth traces its origins to James M. Cox, who began his career with the acquisition of the Dayton Evening News. Over time, this company evolved into Cox Enterprises, a distinguished media conglomerate boasting a global workforce of more than 50,000 employees and achieving an impressive annual revenue of approximately $20 billion.
The core focus of Cox Enterprises lies in strategic investments worldwide, with particular emphasis on real estate, private equity, venture capital, and direct investments. Their interests span across various sectors and industries, including technology, agriculture, CleanTech, energy, automotive, artificial intelligence, software, healthcare, among others. Notably, Cox Enterprises frequently assumes the role of lead investor and is open to co-investing, exhibiting a willingness to invest in projects at different stages of funding.
In August 2022, the company played a pivotal role as the lead investor in a significant Series A funding round that raised $14 million for Motivo Health, an Atlanta-based organization striving to offer accessible and affordable clinical supervision to therapists. Motivo Health's mission revolves around combatting the mental health crises prevalent in the United States by enabling remote supervision and simplifying licensing requirements at the state level, thereby reducing associated costs and timelines. Earlier, in November 2021, Cox Enterprises spearheaded another funding round amounting to $58 million for Enlace Health, formerly known as Aver, Inc. Headquartered in Columbus, Ohio, Enlace Health is a healthcare technology company committed to providing a platform for providers and payers to transition from fee-for-service models to value-based care arrangements. This transformation aims to enhance patient outcomes, lower expenses, and improve overall healthcare quality. According to the report by Business Wire, part of this funding was dedicated to rebranding the company, while the remaining funds were utilized to expedite the company's expansion plans.
FINTRX is a unified family office and registered investment advisor (RIA) database that provides comprehensive data intelligence on 850,000+ family office & investment advisor records, each designed to help asset-raising professionals identify, access and map the global private wealth ecosystem.
Find relevant private wealth decision-makers in a snap with powerful search filters and queries. Uncover the data you need, when you need it and filter through areas of investment interest, AUM, asset flows, intent signals, potential associates and more. FINTRX sources data from both public and private sources and has a team of 75+ researchers who map, validate and compile data daily to ensure its accuracy.